Tag: stent retriever

Getting it right the first time: Commit to a first-pass effect...

Advertorial While the treatment paradigm for stroke continues to evolve, even a quick review of the current literature will point to how complete reperfusion...

Combining contact aspiration with stent retriever techniques elicits no superiority

The first randomised controlled trial (RCT) to directly compare the efficacy of the combined use of contact aspiration and stent retriever against a stent...

Favourable revascularisation rates for first-in-man results of the Versi Retriever in...

First-in-man results of the Versi Retriever (NeuroVasc Technologies) in acute ischaemic stroke patients with large vessel occlusions demonstrate a promising safety profile and efficacious...

First patient enrolled in TIGER pivotal clinical study

The first patients have been enrolled in the TIGER (Treatment with Intent to Generate Reperfusion) study. This is a multicentre study of the performance...

Long stent retrievers associated with increased rates of first-pass reperfusion

Longer stent retrievers were found independently associated with higher rates of first-pass reperfusion and should be favoured over their shorter counterparts in light of...

To By-Pass or Not To By-Pass

In this educational supplement we focus on ischaemic stroke. We look at the results of the ASTER trial and experts weigh in on the...

ASTER final data confirm no difference between ADAPT and stent retriever...

The final results of the ASTER randomised controlled trial have confirmed that there was no statistically significant difference between ADAPT (a direct aspiration first...

Stent retrievers more harmful to arterial wall than ADAPT in animal...

A new study comparing acute damage to the arterial wall caused by ADAPT (a direct aspiration first pass technique) or stent retrievers during thrombectomy...

New stent retriever introduces novel clot capture mechanism

Now that mechanical thrombectomy for the treatment of acute ischaemic stroke is on its way to becoming well-established practice, new devices are beginning to...

Neuravi announces European launch of EmboTrap II stent retriever for treatment...

Neuravi has received CE mark approval for newly available enhancements to its EmboTrap stent retriever platform, the EmboTrap II revascularisation device. The company will...

US FDA broadens treatment indication for Stryker’s Trevo device

The US Food and Drug Administration (FDA) has allowed marketing of two Trevo (Stryker Neurovascular) clot retrieval devices as an initial therapy for ischaemic...

Randomised trial of Penumbra 3D revascularisation device meets primary endpoints

The Penumbra 3D trial of the company’s 3D revascularisation device has successfully met the primary trial endpoints, demonstrating non-inferiority in both safety and efficacy...

Stent retriever technology named as a Top Medical Innovation by Cleveland...

Stent retriever technology has been named by the Cleveland Clinic as a top medical innovation. It was part of a list of the top...

Evidence builds for endovascular treatment of acute ischaemic stroke

With the publication of two more stroke trials, the evidence in favour of endovascular treatment in patients with acute ischaemic stroke has reached new heights. Data from SWIFT PRIME and REVASCAT add to that of three other trials-MR CLEAN, EXTEND-IA and ESCAPE-that have begun to change the face of ischaemic stroke treatment.

Groundbreaking studies find that neurointerventional surgery reduces stroke mortality

Two new clinical trials on the treatment of stroke (ESCAPE and EXTEND IA) demonstrate that neurointerventional surgery significantly increases the number of patients who are able to live independently without major neurological disabilities.